Literature DB >> 10402500

Apo E genotypes and risk of dementia in Down syndrome.

D C Rubinsztein1, J Hon, F Stevens, I Pyrah, C Tysoe, F A Huppert, D F Easton, A J Holland.   

Abstract

The relationship between apo E genotypes and risk of dementia in Down syndrome is not clear. Accordingly, we have analysed this locus in 20 demented and 25 nondemented individuals with Down syndrome and combined these data with other studies in a meta-analysis. The meta-analysis revealed an estimated odds ratio for dementia of 2.74 (95% CI 1.34-5.58) (P =.0004) for apo epsilon4 carriers compared with apo epsilon3/epsilon3, similar to that observed in late-onset Alzheimer's disease. An additional parallel with late-onset Alzheimer's disease was shown by the apo epsilon2 allele, which was associated with decreased dementia risk in Down syndrome (odds ratio for apo epsilon2/epsilon2 + epsilon2/epsilon3 = 0.37 (95% CI 0.14-0. 96)). Thus, apo E genotypes are associated with similar risk effects in Down syndrome dementia and late-onset Alzheimer's disease. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10402500     DOI: 10.1002/(sici)1096-8628(19990820)88:4<344::aid-ajmg10>3.0.co;2-1

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

1.  Alzheimer's Disease in Adults with Down Syndrome.

Authors:  Warren B Zigman; Darlynne A Devenny; Sharon J Krinsky-McHale; Edmund C Jenkins; Tiina K Urv; Jerzy Wegiel; Nicole Schupf; Wayne Silverman
Journal:  Int Rev Res Ment Retard       Date:  2008-01-01

Review 2.  Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.

Authors:  Eric D Hamlett; Heather A Boger; Aurélie Ledreux; Christy M Kelley; Elliott J Mufson; Maria F Falangola; David N Guilfoyle; Ralph A Nixon; David Patterson; Nathan Duval; Ann-Charlotte E Granholm
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

Review 3.  The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD.

Authors:  Sally Hunter; Thomas Arendt; Carol Brayne
Journal:  Mol Neurobiol       Date:  2013-04-03       Impact factor: 5.590

4.  Choroid Plexus Acts as Gatekeeper for TREM2, Abnormal Accumulation of ApoE, and Fibrillary Tau in Alzheimer's Disease and in Down Syndrome Dementia.

Authors:  Ruma Raha-Chowdhury; James W Henderson; Animesh Alexander Raha; Romina Vuono; Anastasia Bickerton; Elizabeth Jones; Robert Fincham; Kieren Allinson; Anthony Holland; Shahid H Zaman
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

5.  Apolipoprotein e: essential catalyst of the Alzheimer amyloid cascade.

Authors:  Huntington Potter; Thomas Wisniewski
Journal:  Int J Alzheimers Dis       Date:  2012-07-15

6.  Genetic variants conferring susceptibility to Alzheimer's disease in the general population; do they also predispose to dementia in Down's syndrome.

Authors:  Ashok Patel; Simon D Rees; M Ann Kelly; Stephen C Bain; Anthony H Barnett; Anisha Prasher; Humaria Arshad; Vee P Prasher
Journal:  BMC Res Notes       Date:  2014-01-17

7.  Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.

Authors:  Ruma Raha-Chowdhury; James W Henderson; Animesh Alexander Raha; Simon R W Stott; Romina Vuono; Simona Foscarin; Liam Wilson; Tiina Annus; Robert Fincham; Kieren Allinson; Vinod Devalia; Robert P Friedland; Anthony Holland; Shahid H Zaman
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

8.  Sex differences in risk of Alzheimer's disease in adults with Down syndrome.

Authors:  Florence Lai; Pooja G Mhatre; Yuchen Yang; Mei-Cheng Wang; Nicole Schupf; H Diana Rosas
Journal:  Alzheimers Dement (Amst)       Date:  2020-09-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.